Early last year, a hundred researchers, clinicians and other experts on HIV discussed the development of an innovative vaccine that could prevent the disease. But just as the meeting was about to wrap ...

An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site ...

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Everything had been leading to the meeting early last year in Zanzibar, a tropical archipelago off the east coast of Africa. A hundred researchers, clinicians and other experts on HIV from across ...

South Africa begins human trials of a locally developed HIV vaccine, marking a potential turning point in fight against HIV and AIDS.

Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single ...

The trial is taking place at the Desmond Tutu HIV Foundation, located at Groote Schuur Hospital in Cape Town. It is the first ...

Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have contracted the virus and an additional 44.1 million have died from related causes ...